Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C Represents QIAGEN N.V. In Major Convertible Note Offering

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Attorneys in the Corporate & Securities and Life Sciences Practices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., together with European counsel, recently represented QIAGEN N.V. in a major offering of convertible notes. The transactions included the simultaneous repurchase from non-U.S. holders of approximately $291 million of outstanding convertible notes, the issuance of $730 million aggregate principal amount of new senior unsecured cash-settled convertible notes outside the United States, and the implementation of a call spread overlay increasing the effective strike price of the new convertible notes from QIAGEN’s perspective.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC